Top Markets
#1 Prom Prom +33.92%
#2 QuantixAI QuantixAI +31.15%
#3 MowCat MowCat +27.76%
#4 UnifAI Network UnifAI Network +22.91%
#5 Tutorial Tutorial +21.17%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +18.79%
#7 Pons Pons +16.95%
#8 Versatize Coin Versatize Coin +16.65%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +16.49%
#10 Derive Derive +14.63%
Coin of the day
Prom Prom
Settings
Language
ENGLISH
Currency
USD
Theme
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Rank in Stocks #20516
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Share Price
$20.27
Market Cap
$128.37M
Change (1 day)
-1.37%
Change (1 year)
79.91%
Country
PL
Trade Captor Therapeutics Spolka Akcyjna (CTX)

Category

Healthcare
Stock price history for Captor Therapeutics Spolka Akcyjna (CTX)
Highest end of day price: $20.25 on 2026-08-01

Lowest end of day price: $45.81 on 2021-04-01
Stock price history of Captor Therapeutics Spolka Akcyjna from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -1.92%
2025 68.95%
2024 -54.45%
2023 -32.61%
2022 -15.45%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.27 -15.19%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $766.03 8.39%
CH